Company · CIK 0001679628 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
JUPITER NEUROSCIENCES, INC. · JUNS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Julie B. KampfDirector | 82,875 | — | — | 82,875 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Alexander Gustaf Erik RosenChief Administrative Officer | 261,161 | — | — | 617,411 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Marshall A. HaywardChief Scientific Officer, Director | 1,014,195 | — | — | 2,995,077 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Nicholas H. HemmerlyDirector | 95,550 | — | — | 95,550 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Holger WeisDirector | 85,800 | — | — | 96,581 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 AForm 4 → | Aug 5, 4:05 pm EDT | Andrew Jon CutlerDirector | 472,222 | — | — | 472,222 | — | late |
| Jun 29, 2026 AForm 4 → | Jul 1, 4:02 pm EDT | Tomas Jan PhilipsonDirector | 536,428 | — | — | 536,428 | — | |
| Jun 2, 2026 AForm 4 → | Jun 5, 8:23 am EDT | Allison W BradyDirector | 100,000 | — | — | 100,000 | — | late |
| Jun 2, 2026 AForm 4 → | Jun 4, 9:01 pm EDT | Saleem ElmasriChief Financial Officer | 525,565 | — | — | 525,565 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 9:00 pm EDT | Christer RosenCEO and Chairman, Director | 747,783 | — | — | 747,783 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 9:00 pm EDT | Nicholas H. HemmerlyDirector | 100,000 | — | — | 100,000 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 9:00 pm EDT | Julie B. KampfDirector | 100,000 | — | — | 100,000 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 9:00 pm EDT | Alison D. SilvaPresident and COO, Director | 1,027,304 | — | — | 1,027,304 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 9:00 pm EDT | Marshall A. HaywardChief Scientific Officer, Director | 259,231 | — | — | 259,231 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 8:47 pm EDT | Holger WeisDirector | 100,000 | — | — | 100,000 | — | |
| Jun 2, 2026 AForm 4 → | Jun 4, 8:46 pm EDT | Alexander Gustaf Erik RosenChief Administrative Officer | 341,843 | — | — | 341,843 | — | |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Julie B. KampfDirector | 82,875 | — | — | 0 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Alexander Gustaf Erik RosenChief Administrative Officer | 261,162 | — | — | 0 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Marshall A. HaywardChief Scientific Officer, Director | 1,014,195 | — | — | 0 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Nicholas H. HemmerlyDirector | 95,550 | — | — | 0 | — | late |
| Jun 2, 2025 MForm 4 → | Jul 13, 2026, 4:00 pm EDT | Holger WeisDirector | 85,800 | — | — | 0 | — | late |